patents articles ↓

Another step in the ongoing battle between Galderma and Mylan over the right to manufacture generic Oracea. A judge has declared that Mylan infringes 1 of the patents that protects Oracea from generic copies. Some History …

The recently published paper that called for the creation of Neurogenic Rosacea subtype contained an interesting disclosure.

We are told that one of the paper’s authors, Professor Martin Steinhoff MD PhD , holds a related patent and research grant from Galderma.
Related Rosacea Grant
Dr. Steinhoff, along with Dr. Feramisco, received a $25,000 grant in 2010 from the National Rosacea Society.

Perhaps this below is the grant …

Trolling patent applications is pretty turgid work. Mostly patents seem to be intellectuals marking out their claims in the hope that future products might result from their discoveries. This patent application starts badly with firstly spelling Rosacea incorrectly as Rosascea. …

A recently updated patent, assigned to Galderma suggests a rosacea topical comprising “at least one compound of the avermectin family and benzoyl peroxide”. This is an unusual (or novel, depending on your viewpoint I suppose) pairing of ingredients for a topical treatment for rosacea symptoms. If you search patents online you can also find applications for topicals containing Avermectin + Metronidazole and …

The battle to make generic Oracea available to the public is heating up. Recently filed documents in Delaware show that Lupin Pharmaceuticals, which are based in India have filed for …